Consultant Gastroenterologist, AIG Hospital.
Special interest in IBD, small and large bowel pathologies.
01001101 01000100 01000100 01001101
PGIMER Alma mater
The JAMA Network is accepting applications for two training programs designed to support early‑career researchers interested in scholarly publishing.
✍️ Peer Review Academy
📚 Editorial Fellowship
Learn more about both and apply now: https://t.co/bSilIswxTZ
@albertoortegana@drkeithsiau Right to some extent, but often these are not the locations for an ideal paracentesis. These are scars from burns, which is often used in traditional medicine for Jaundice.
Interested in Global 🌎 #IBD
We have a FREE in-person ( for 🇬🇧 HCPs) and online #IBD educational event at Hull on 20th &21st July
🌟Stellar Faculty
🌟Practical #IBD care tips
🌟Hot topics in #IBD
🌟Great debates
Do register free.
https://t.co/4ZO9eAytyS
India and many Emerging nations of the global south are in epidemiological acceleration phase of IBD, this journal is the need of the hour. It will provide a platform for practicing IBD specialists and young researchers to showcase, share, and advance work in IBD @ibd_enc
Comparative effectiveness of mirikizumab and risankizumab in patients with ulcerative colitis: A propensity-matched cohort study
@GKochharMD et al
https://t.co/QnyDagzIRo
New - Intestinal ultrasound to detect postoperative recurrence in patients with Crohn's disease: an international, multidisciplinary, RAND/UCLA appropriateness method study
https://t.co/uxmwqFD0a3
#GITwitter#MedTwitter
🆕#IBD issue of the @IJG_Journal
➡️ Two systematic reviews on diet in IBD
➡️ Three guidance documents thanks to @CCF_IN and @IsgSecretariat on Histology for IBD, Perianal CD, Histology to discriminate GITB and Crohns
📖Do read it here
https://t.co/BqwrOMMbQm
Mr Beast talks about living with Crohn’s disease since the age of 15. Treatment with Remicade has left him susceptible to infections such as flu, shingles and COVID six times, but has not stopped him from reaching his dreams. What an inspiration!
Very happy to share that our paper on sarcopenia and frailty in #IBD is a top cited article @JGHofficial@WileyHealth for 2024–2025. Thank @drvishal82 sir for the guidance and opportunity.
@ibd_enc 's Editorial Recommendations – April 2026
-Statins ↓ stricture risk in Crohn’s
-Personalized infliximab in ASUC
-UST vs IFX in perianal CD
-Rising IBD burden in India
-Updated surveillance guidelines
More at: https://t.co/XlK4XdHT89
#IBD#Gastroenterology#MedTwitter